Ajay Kirtane
Overview
Explore the profile of Ajay Kirtane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balter S, Moses J, Hyasat K, Collins M, Kirtane A, McEntegart M, et al.
Am Heart J
. 2025 Jan;
283:5-16.
PMID: 39832634
Background: This retrospective study addresses the role of operator and fluoroscopy equipment in reducing patient radiation exposure in the Cath lab. Methods: Data from 99,400 procedures performed in our institution...
2.
Byrne R, Colleran R, Coughlan J, Jauhar R, Maillard L, De Labriolle A, et al.
Circ Cardiovasc Interv
. 2024 Oct;
17(10):e013735.
PMID: 39405373
Background: Patients with an indication for oral anticoagulation who undergo percutaneous coronary intervention require a combination of oral anticoagulation and antiplatelet therapy. The use of a coronary stent with a...
3.
Mufarrih S, Qureshi N, Khan M, Kazimuddin M, Secemsky E, Bloch M, et al.
J Am Heart Assoc
. 2024 Aug;
13(16):e034910.
PMID: 39140334
Background: Despite optimal medical therapy, a significant proportion of patients' blood pressure remains uncontrolled. Catheter-based renal denervation (RDN) has been proposed as a potential intervention for uncontrolled hypertension. We conducted...
4.
Vukadinovic D, Lauder L, Kandzari D, Bhatt D, Kirtane A, Edelman E, et al.
medRxiv
. 2024 Jul;
PMID: 38946962
Background: Several sham-controlled trials have investigated the efficacy and safety of catheter-based renal denervation (RDN) with mixed outcomes. Aim: To perform a comprehensive meta-analysis of all randomized, sham-controlled trials investigating...
5.
White R, Lam P, Lu N, Su X, Bergemann T, Johnson T, et al.
Cardiovasc Revasc Med
. 2024 Jun;
69:90-97.
PMID: 38897847
In 2020, the NIH and FDA issued guidance documents that laid the foundation for human subject research during an unprecedented pandemic. To bridge these general considerations to actual applications in...
6.
Vora A, Gada H, Manandhar P, Kosinski A, Kirtane A, Nazif T, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(3):391-401.
PMID: 38355267
Background: Although permanent pacemaker (PPM) implantation is a common complication of transcatheter aortic valve replacement (TAVR), hospital variation and change in PPM implantation rates are ill defined. Objectives: The aim...
7.
Mahfoud F, Azizi M, Daemen J, Sharp A, Patak A, Iglesias J, et al.
Clin Res Cardiol
. 2023 Nov;
113(10):1375-1383.
PMID: 37943324
Background: Hypertension is a major public health issue due to its association with cardiovascular disease risk. Despite the availability of effective antihypertensive drugs, rates of blood pressure (BP) control remain...
8.
Karacsonyi J, Kostantinis S, Simsek B, Basir M, Megaly M, Ali Z, et al.
J Invasive Cardiol
. 2023 May;
35(5):E265-E268.
PMID: 37169391
Background: Intravascular ultrasound (IVUS) can assist percutaneous coronary intervention (PCI) of chronic total occlusions (CTO). Methods: We analyzed 8,983 CTO PCIs performed in 8,771 patients between 2012 and 2022 at...
9.
10.
Nelson A, Wegermann Z, Gallup D, OBrien S, Kosinski A, Thourani V, et al.
JAMA Cardiol
. 2023 Apr;
8(5):492-502.
PMID: 37017940
Importance: Professional societies and the Centers for Medicare & Medicaid Services suggest volume thresholds to ensure quality in transcatheter aortic valve implantation (TAVI). Objective: To model the association of volume...